{"transactions":[{"id":307711,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-06-30T20:09:42.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":596,"price":482.5,"value":287570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":15337,"source":{"system":"sec-edgar","filing":"0000875320-26-000239","document":"wk-form4_1782850180.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000239/wk-form4_1782850180.xml","form_type":"4"}},{"id":307946,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-06-23T20:08:57.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1020,"price":462.17,"value":471413.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":15933,"source":{"system":"sec-edgar","filing":"0000875320-26-000237","document":"wk-form4_1782245334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000237/wk-form4_1782245334.xml","form_type":"4"}},{"id":308211,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-06-17T20:12:35.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":4062,"price":450,"value":1827900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":16953,"source":{"system":"sec-edgar","filing":"0000875320-26-000235","document":"wk-form4_1781727153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000235/wk-form4_1781727153.xml","form_type":"4"}},{"id":308630,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-06-09T20:24:24.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":1745,"price":450,"value":785250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":21015,"source":{"system":"sec-edgar","filing":"0000875320-26-000233","document":"wk-form4_1781036661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000233/wk-form4_1781036661.xml","form_type":"4"}},{"id":308852,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-06-02T20:04:23.000Z","date":"2026-05-29","kind":"sale","planned":true,"acquired":false,"shares":1974,"price":450,"value":888300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":22760,"source":{"system":"sec-edgar","filing":"0000875320-26-000228","document":"wk-form4_1780430661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000228/wk-form4_1780430661.xml","form_type":"4"}},{"id":309435,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-05-19T20:04:21.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":1354,"price":453.45,"value":613971.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":24734,"source":{"system":"sec-edgar","filing":"0000875320-26-000225","document":"wk-form4_1779221059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000225/wk-form4_1779221059.xml","form_type":"4"}},{"id":309670,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-05-14T20:10:04.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":6988,"price":450,"value":3144600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":26088,"source":{"system":"sec-edgar","filing":"0000875320-26-000222","document":"wk-form4_1778789402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000222/wk-form4_1778789402.xml","form_type":"4"}},{"id":311134,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-03-31T20:10:23.000Z","date":"2026-03-27","kind":"sale","planned":true,"acquired":false,"shares":2329,"price":450.95,"value":1050262.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":33076,"source":{"system":"sec-edgar","filing":"0000875320-26-000149","document":"wk-form4_1774987818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000149/wk-form4_1774987818.xml","form_type":"4"}},{"id":311546,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-03-17T20:04:23.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":2329,"price":481.79,"value":1122088.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":35405,"source":{"system":"sec-edgar","filing":"0000875320-26-000140","document":"wk-form4_1773777858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000140/wk-form4_1773777858.xml","form_type":"4"}},{"id":312323,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-03-03T21:25:20.000Z","date":"2026-02-27","kind":"sale","planned":true,"acquired":false,"shares":2329,"price":480.31,"value":1118641.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025."}],"balance_after":37734,"source":{"system":"sec-edgar","filing":"0000875320-26-000127","document":"wk-form4_1772573117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000127/wk-form4_1772573117.xml","form_type":"4"}},{"id":312733,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-02-26T23:05:21.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1453,"price":485.11,"value":704864.83,"ownership":{"direct":true},"balance_after":40063,"source":{"system":"sec-edgar","filing":"0000875320-26-000110","document":"wk-form4_1772147118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000110/wk-form4_1772147118.xml","form_type":"4"}},{"id":313145,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-02-19T21:10:59.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1912,"price":483.75,"value":924930.0,"ownership":{"direct":true},"balance_after":41516,"source":{"system":"sec-edgar","filing":"0000875320-26-000086","document":"wk-form4_1771535456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000086/wk-form4_1771535456.xml","form_type":"4"}},{"id":313144,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-02-19T21:10:59.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":5375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on February 20, 2027."}],"balance_after":43428,"source":{"system":"sec-edgar","filing":"0000875320-26-000086","document":"wk-form4_1771535456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000086/wk-form4_1771535456.xml","form_type":"4"}},{"id":313477,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-02-18T21:28:44.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":3804,"price":487.76,"value":1855439.04,"ownership":{"direct":true},"balance_after":38053,"source":{"system":"sec-edgar","filing":"0000875320-26-000066","document":"wk-form4_1771450120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000066/wk-form4_1771450120.xml","form_type":"4"}},{"id":313865,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-02-12T21:53:25.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2145,"price":468.41,"value":1004739.45,"ownership":{"direct":true},"balance_after":41857,"source":{"system":"sec-edgar","filing":"0000875320-26-000042","document":"wk-form4_1770933202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000042/wk-form4_1770933202.xml","form_type":"4"}},{"id":314834,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-01-26T21:22:18.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":3467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/12/2025 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest in installments beginning on 02/24/2026."}],"balance_after":44002,"source":{"system":"sec-edgar","filing":"0000875320-26-000016","document":"wk-form4_1769462535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000016/wk-form4_1769462535.xml","form_type":"4"}},{"id":314833,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2026-01-26T21:22:18.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":7866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest on 02/13/2026."}],"balance_after":40535,"source":{"system":"sec-edgar","filing":"0000875320-26-000016","document":"wk-form4_1769462535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000016/wk-form4_1769462535.xml","form_type":"4"}},{"id":325022,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2025-02-28T21:41:17.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4962,"price":479.61,"value":2379824.82,"ownership":{"direct":true},"balance_after":32669,"source":{"system":"sec-edgar","filing":"0000875320-25-000129","document":"wk-form4_1740778869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000129/wk-form4_1740778869.xml","form_type":"4"}},{"id":325178,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2025-02-26T21:11:00.000Z","date":"2025-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3310,"price":483.28,"value":1599656.8,"ownership":{"direct":true},"balance_after":37631,"source":{"system":"sec-edgar","filing":"0000875320-25-000109","document":"wk-form4_1740604253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000109/wk-form4_1740604253.xml","form_type":"4"}},{"id":325784,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2025-02-19T21:30:24.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1912,"price":463.46,"value":886135.52,"ownership":{"direct":true},"balance_after":40941,"source":{"system":"sec-edgar","filing":"0000875320-25-000087","document":"wk-form4_1740000615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000087/wk-form4_1740000615.xml","form_type":"4"}},{"id":326069,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2025-02-14T21:11:56.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":5546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on 02/24/2026."}],"balance_after":42853,"source":{"system":"sec-edgar","filing":"0000875320-25-000065","document":"wk-form4_1739567507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000065/wk-form4_1739567507.xml","form_type":"4"}},{"id":326170,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2025-02-12T21:38:37.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2142,"price":467.98,"value":1002413.16,"ownership":{"direct":true},"balance_after":37307,"source":{"system":"sec-edgar","filing":"0000875320-25-000041","document":"wk-form4_1739396310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000041/wk-form4_1739396310.xml","form_type":"4"}},{"id":326554,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2025-02-06T21:35:36.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":5928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025."}],"balance_after":39449,"source":{"system":"sec-edgar","filing":"0000875320-25-000016","document":"wk-form4_1738877728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000016/wk-form4_1738877728.xml","form_type":"4"}},{"id":326553,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2025-02-06T21:35:36.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":10262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025."}],"balance_after":33521,"source":{"system":"sec-edgar","filing":"0000875320-25-000016","document":"wk-form4_1738877728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000016/wk-form4_1738877728.xml","form_type":"4"}},{"id":331591,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-08-08T20:06:24.000Z","date":"2024-08-07","kind":"sale","planned":true,"acquired":false,"shares":2280,"price":476.75,"value":1086990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024."}],"balance_after":23259,"source":{"system":"sec-edgar","filing":"0000875320-24-000202","document":"wk-form4_1723147577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000202/wk-form4_1723147577.xml","form_type":"4"}},{"id":331896,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-07-25T20:06:02.000Z","date":"2024-07-24","kind":"sale","planned":true,"acquired":false,"shares":2280,"price":488.46,"value":1113688.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024."}],"balance_after":25539,"source":{"system":"sec-edgar","filing":"0000875320-24-000189","document":"wk-form4_1721937956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000189/wk-form4_1721937956.xml","form_type":"4"}},{"id":332218,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-07-12T20:07:11.000Z","date":"2024-07-10","kind":"sale","planned":true,"acquired":false,"shares":2280,"price":487.34,"value":1111135.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024."}],"balance_after":27819,"source":{"system":"sec-edgar","filing":"0000875320-24-000183","document":"wk-form4_1720814825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000183/wk-form4_1720814825.xml","form_type":"4"}},{"id":332478,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-06-28T20:04:38.000Z","date":"2024-06-26","kind":"sale","planned":true,"acquired":false,"shares":2280,"price":471.72,"value":1075521.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024."}],"balance_after":30099,"source":{"system":"sec-edgar","filing":"0000875320-24-000181","document":"wk-form4_1719605071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000181/wk-form4_1719605071.xml","form_type":"4"}},{"id":332797,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-06-13T20:11:34.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":2280,"price":478,"value":1089840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024."}],"balance_after":32379,"source":{"system":"sec-edgar","filing":"0000875320-24-000176","document":"wk-form4_1718309487.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000176/wk-form4_1718309487.xml","form_type":"4"}},{"id":333197,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-05-31T20:19:42.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":2280,"price":445.56,"value":1015876.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024."}],"balance_after":34659,"source":{"system":"sec-edgar","filing":"0000875320-24-000164","document":"wk-form4_1717186773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000164/wk-form4_1717186773.xml","form_type":"4"}},{"id":339123,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-02-27T21:50:38.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3309,"price":431.79,"value":1428793.11,"ownership":{"direct":true},"balance_after":36939,"source":{"system":"sec-edgar","filing":"0000875320-24-000103","document":"wk-form4_1709070601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000103/wk-form4_1709070601.xml","form_type":"4"}},{"id":339695,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-02-21T21:26:45.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2812,"price":420.58,"value":1182670.96,"ownership":{"direct":true},"balance_after":40248,"source":{"system":"sec-edgar","filing":"0000875320-24-000072","document":"wk-form4_1708550788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000072/wk-form4_1708550788.xml","form_type":"4"}},{"id":339694,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-02-21T21:26:45.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3750,"price":424.01,"value":1590037.5,"ownership":{"direct":true},"balance_after":43060,"source":{"system":"sec-edgar","filing":"0000875320-24-000072","document":"wk-form4_1708550788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000072/wk-form4_1708550788.xml","form_type":"4"}},{"id":340496,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-02-13T22:01:14.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2100,"price":422.74,"value":887754.0,"ownership":{"direct":true},"balance_after":46810,"source":{"system":"sec-edgar","filing":"0000875320-24-000049","document":"wk-form4_1707861651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000049/wk-form4_1707861651.xml","form_type":"4"}},{"id":341077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-02-08T21:33:06.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":5928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/17/2025."}],"balance_after":48910,"source":{"system":"sec-edgar","filing":"0000875320-24-000024","document":"wk-form4_1707427972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000024/wk-form4_1707427972.xml","form_type":"4"}},{"id":341076,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-02-08T21:33:06.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":7866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on  02/06/2024 and the shares will vest in installments beginning on 02/10/2024."}],"balance_after":42982,"source":{"system":"sec-edgar","filing":"0000875320-24-000024","document":"wk-form4_1707427972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000024/wk-form4_1707427972.xml","form_type":"4"}},{"id":341075,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2024-02-08T21:33:06.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":5814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation\ncommittee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024."}],"balance_after":35116,"source":{"system":"sec-edgar","filing":"0000875320-24-000024","document":"wk-form4_1707427972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000024/wk-form4_1707427972.xml","form_type":"4"}},{"id":344437,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-11-16T21:15:32.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":5650,"price":380.82,"value":2151633.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 05/30/2023."}],"balance_after":29302,"source":{"system":"sec-edgar","filing":"0000875320-23-000037","document":"wk-form4_1700169311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000037/wk-form4_1700169311.xml","form_type":"4"}},{"id":344825,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-11-02T20:07:20.000Z","date":"2023-10-31","kind":"sale","planned":true,"acquired":false,"shares":5651,"price":355.92,"value":2011303.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 05/30/2023."}],"balance_after":34952,"source":{"system":"sec-edgar","filing":"0000875320-23-000025","document":"wk-form4_1698955627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000025/wk-form4_1698955627.xml","form_type":"4"}},{"id":345014,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-10-19T20:18:28.000Z","date":"2023-10-17","kind":"sale","planned":true,"acquired":false,"shares":5651,"price":373.25,"value":2109235.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 05/30/2023."}],"balance_after":40603,"source":{"system":"sec-edgar","filing":"0001209191-23-053178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123053178/doc4.xml","form_type":"4"}},{"id":345325,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-10-05T20:30:27.000Z","date":"2023-10-03","kind":"sale","planned":true,"acquired":false,"shares":5651,"price":345.28,"value":1951177.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 05/30/2023."}],"balance_after":46254,"source":{"system":"sec-edgar","filing":"0001209191-23-052202","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123052202/doc4.xml","form_type":"4"}},{"id":345690,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-09-21T20:15:36.000Z","date":"2023-09-19","kind":"sale","planned":true,"acquired":false,"shares":5651,"price":351,"value":1983501.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 05/30/2023."}],"balance_after":51905,"source":{"system":"sec-edgar","filing":"0001209191-23-050259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123050259/doc4.xml","form_type":"4"}},{"id":345937,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-09-07T20:29:38.000Z","date":"2023-09-05","kind":"sale","planned":true,"acquired":false,"shares":5651,"price":352.66,"value":1992881.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 05/30/2023."}],"balance_after":57556,"source":{"system":"sec-edgar","filing":"0001209191-23-048624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123048624/doc4.xml","form_type":"4"}},{"id":352330,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-02-28T21:50:43.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":3308,"price":289.12,"value":956408.96,"ownership":{"direct":true},"balance_after":63207,"source":{"system":"sec-edgar","filing":"0001209191-23-013713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123013713/doc4.xml","form_type":"4"}},{"id":352892,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-02-22T21:32:29.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":3750,"price":292.85,"value":1098187.5,"ownership":{"direct":true},"balance_after":66515,"source":{"system":"sec-edgar","filing":"0001209191-23-011680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123011680/doc4.xml","form_type":"4"}},{"id":353532,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-02-14T21:55:30.000Z","date":"2023-02-13","kind":"tax_withholding","acquired":false,"shares":4992,"price":298.26,"value":1488913.92,"ownership":{"direct":true},"balance_after":70265,"source":{"system":"sec-edgar","filing":"0001209191-23-009190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123009190/doc4.xml","form_type":"4"}},{"id":353531,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-02-14T21:55:30.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":2707,"price":294.33,"value":796751.31,"ownership":{"direct":true},"balance_after":75257,"source":{"system":"sec-edgar","filing":"0001209191-23-009190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123009190/doc4.xml","form_type":"4"}},{"id":354158,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-02-03T21:44:58.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":7866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/10/2024."}],"balance_after":77964,"source":{"system":"sec-edgar","filing":"0001209191-23-006934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006934/doc4.xml","form_type":"4"}},{"id":354157,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-02-03T21:44:58.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest in installments beginning on 02/24/2023."}],"balance_after":70098,"source":{"system":"sec-edgar","filing":"0001209191-23-006934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006934/doc4.xml","form_type":"4"}},{"id":354156,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2023-02-03T21:44:58.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest on 02/13/2023."}],"balance_after":59836,"source":{"system":"sec-edgar","filing":"0001209191-23-006934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123006934/doc4.xml","form_type":"4"}},{"id":360719,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2022-06-02T20:06:24.000Z","date":"2022-05-31","kind":"tax_withholding","acquired":false,"shares":311,"price":271.24,"value":84355.64,"ownership":{"direct":true},"balance_after":49512,"source":{"system":"sec-edgar","filing":"0000899243-22-020677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322020677/doc4.xml","form_type":"4"}},{"id":365013,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2022-02-28T22:20:31.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":1242,"price":227.86,"value":283002.12,"ownership":{"direct":true},"balance_after":49823,"source":{"system":"sec-edgar","filing":"0000899243-22-008112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322008112/doc4.xml","form_type":"4"}},{"id":365565,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2022-02-22T21:55:22.000Z","date":"2022-02-17","kind":"tax_withholding","acquired":false,"shares":3439,"price":232.51,"value":799601.89,"ownership":{"direct":true},"balance_after":51065,"source":{"system":"sec-edgar","filing":"0000899243-22-007206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322007206/doc4.xml","form_type":"4"}},{"id":366088,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2022-02-14T21:14:50.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":2437,"price":237.74,"value":579372.38,"ownership":{"direct":true},"balance_after":54504,"source":{"system":"sec-edgar","filing":"0001209191-22-009234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122009234/doc4.xml","form_type":"4"}},{"id":366675,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2022-02-03T21:14:28.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":10262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/24/2023."}],"balance_after":56941,"source":{"system":"sec-edgar","filing":"0001209191-22-006770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006770/doc4.xml","form_type":"4"}},{"id":366674,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2022-02-03T21:14:28.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":11628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest in installments beginning on 02/17/2022."}],"balance_after":46679,"source":{"system":"sec-edgar","filing":"0001209191-22-006770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006770/doc4.xml","form_type":"4"}},{"id":366673,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2022-02-03T21:14:28.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":2098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 05/20/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest on 02/24/2022."}],"balance_after":35051,"source":{"system":"sec-edgar","filing":"0001209191-22-006770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006770/doc4.xml","form_type":"4"}},{"id":374796,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2021-06-02T20:06:53.000Z","date":"2021-05-28","kind":"tax_withholding","acquired":false,"shares":311,"price":210.04,"value":65322.44,"ownership":{"direct":true},"balance_after":32953,"source":{"system":"sec-edgar","filing":"0001209191-21-037127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121037127/doc4.xml","form_type":"4"}},{"id":379385,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2021-02-26T21:12:15.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":311,"price":217.57,"value":67664.27,"ownership":{"direct":true},"balance_after":33264,"source":{"system":"sec-edgar","filing":"0001209191-21-014713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014713/doc4.xml","form_type":"4"}},{"id":380491,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2021-02-12T21:06:15.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":2367,"price":214.16,"value":506916.72,"ownership":{"direct":true},"balance_after":33575,"source":{"system":"sec-edgar","filing":"0001209191-21-010095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010095/doc4.xml","form_type":"4"}},{"id":380805,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2021-02-05T21:45:40.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":11627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock unit award that vests in installments beginning on 02/17/2022."}],"balance_after":35942,"source":{"system":"sec-edgar","filing":"0001209191-21-008106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008106/doc4.xml","form_type":"4"}},{"id":380804,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2021-02-05T21:45:40.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":10324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest in installments beginning on 02/10/2021."}],"balance_after":24315,"source":{"system":"sec-edgar","filing":"0001209191-21-008106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008106/doc4.xml","form_type":"4"}},{"id":389846,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-06-02T20:14:16.000Z","date":"2020-05-29","kind":"tax_withholding","acquired":false,"shares":311,"price":282.74,"value":87932.14,"ownership":{"direct":true},"balance_after":13991,"source":{"system":"sec-edgar","filing":"0001209191-20-033493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120033493/doc4.xml","form_type":"4"}},{"id":394378,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GMDA"}}],"security":"Common Stock","published_at":"2020-02-26T21:31:59.000Z","date":"2020-02-24","kind":"tax_withholding","acquired":false,"shares":216,"price":239.23,"value":51673.68,"ownership":{"direct":true},"balance_after":14302,"source":{"system":"sec-edgar","filing":"0001209191-20-013023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013023/doc4.xml","form_type":"4"}},{"id":395771,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GMDA"}}],"security":"Common Stock","published_at":"2020-02-07T21:10:27.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":10323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock unit award that vests in installments beginning on 02/10/2021."}],"balance_after":14518,"source":{"system":"sec-edgar","filing":"0001209191-20-007481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120007481/doc4.xml","form_type":"4"}},{"id":395770,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14509,"kind":"person","name":"Bozic Carmen","position":1,"cik":"0001790029","reported_name":"Bozic Carmen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GMDA"}}],"security":"Common Stock","published_at":"2020-02-07T21:10:27.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":2098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 05/20/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 2/24/2020."}],"balance_after":4195,"source":{"system":"sec-edgar","filing":"0001209191-20-007481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120007481/doc4.xml","form_type":"4"}}]}